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ABSTRACT 
Refeeding Syndrome is a syndrome which occurs as a result of food administration in poorly nourished 
individuals. In this syndrome, there are wide range of biochemical alterations, clinical manifestations, and 
complications, starting from mild (asymptomatic) to severe (death). This syndrome was initially proposed 
in 15s however, there is still no agreement for its clear de¿nition, causing clinicians to be less aware and 
tend to overlook this condition. Clinical manifestations which usually appear include electrolyte imbalances 
(hypophosphatemia, hypokalemia, hyponatremia, hypomagnesemia) and vitamin %1 de¿ciency. The main 
principle in management of refeeding syndrome is prevention, where clinicians need to identify this condition 
in the early stage in high risk individuals, supervision during refeeding, and administration of appropriate diet.
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ABSTRAK 
Refeeding Syndrome merupakan sindrom yang terjadi akibat pemberian makan pada individu kurang gizi. 
Pada sindrom ini terjadi perubahan biokimia, manifestasi klinis dan komplikasi yang rentangnya sangat luas, 
mulai dari ringan (tidak bergejala) sampai berat (kematian). Sindrom ini pertama kali dikemukakan pada tahun 
15-an, namun sampai sekarang masih belum ada kesepakatan untuk de¿nisi yang jelas, sehingga membuat 
klinisi tidak waspada dan cenderung terlupakan. Manifestasi klinis yang biasanya muncul adalah gangguan 
elektrolit (hipofosfatemia, hypokalemia, hiponatremia, hipomagnesemia) dan de¿siensi vitamin %1.  Prinsip 
utama dalam penanganan Refeeeding Syndrome adalah pencegahan, dimana klinisi harus mengidenti¿kasi dini 
individu berisiko tinggi, adanya pengawasan saat pemberian makan kembali, dan pemberian diet yang tepat.
Kata kunci: refeeding syndrome, gangguan elektrolit, de¿siensi vitamin %1
INTRODUCTION
Refeeding syndrome (RS) describes biochemical 
alterations, clinical manifestations, and complications 
which can happen due to food administration in 
individuals with catabolic malnutrition. RS has been 
known and recorded in literature since more than 50 
years ago and may cause serious injury and death. 
RS may happen in all individuals, but more often 
to occur in population at risk.1 RS was reported for 
the ¿rst time in 150s, after observation performed 
to malnourished war prisoners who suffered from 
cardiac and neurological symptoms soon after food re-
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administration.2 Until now, there is still no international 
consensus regarding the de¿nition of RS. $s there 
is no precise definition, it is anticipated that the 
incidence of RS is unclear.1 Speci¿c characteristic of 
RS is the presence of hypophosphatemia in patients; 
however, because this is a comple[ syndrome, it may 
also lead to symptoms of Àuid imbalance, abnormal 
sodium level, alteration of glucose, protein, and fat 
metabolism, vitamin %1 de¿ciency, hypokalaemia, 
and hypomagnesemia.3 
The spectrum of clinical manifestations of RS is 
very wide, with various symptoms, unpredictable, 
that may occur without any warning signs, and may 
also appear later. Its symptoms occur as a result of 
alterations in blood electrolytes causing disturbance 
in cell membrane potential, thus interrupts the 
function of neurons, heart, and skeletal muscle. The 
presentations of symptoms start from mild nausea 
and vomiting to breathing problems, heart failure, 
hypotension, arrhythmia, delirium, coma, and death.1 
Although the physiology and pathophysiology of RS 
is well known, conditions causing the appearance of 
RS, clinical manifestations, and management of this 
patient are still unclear. It leads many clinicians to be 
unaware and even forget RS; hence, this condition is 
still happening.1,3 
This article aims to increase the awareness of RS 
and acts as a discussion material for prevention and 
management of RS. Thus, in the future clinicians have 
good ability in diagnostic approach and can manage 
RS in comprehensive and holistic manner.
DEFINITION OF REFEEDING SYNDROME
The ¿rst report regarding RS is published in 150s, 
after observation performed in malnourished war 
prisoners who suffered from cardiac and neurological 
symptoms soon after food re-administration.2 For 
the universal de¿nition of RS, until now there is still 
no approved consensus.4 In their study performed in 
year 2001, Crook et al stated that RS is a syndrome 
marked by the presence of severe Àuid and electrolyte 
imbalance accompanied by metabolic dysfunction in 
malnourished individuals who underwent food re-
administration, either in the form of oral, enteral, or 
parenteral.5
As there is still no strict definition, it is not 
surprising that the incidence rate of RS remains 
unclear.1,3 The number of studies of RS is still limited 
because there is no internationally approved diagnostic 
criteria or guidelines to detect RS.6 Most published 
data is obtained from prospective and retrospective 
case series; thus, do not reÀect the incidence rate in 
general.1,6 
Hypophosphatemia is the most common marker used 
in RS, although low phosphate level in the blood is not 
a pathognomonic condition.7 In a prospective cohort 
study in ICU patients conducted by Marik and Bedigian, 
34% patients suffered from hypophosphatemia soon 
after patients were given food re-administration (mean 
(standard deviation) 1.9 (1.1) days).8 However, this 
condition is frequently undetected, or even do not 
receive appropriate management, particularly in patients 
treated in regular wards.3 
PATHOGENESIS AND PATHOPHYSIOLOGY
The main factor causing the occurrence of RS is 
hormonal and metabolic alterations which are triggered 
by rapid food re-administration, either enteral or 
parenteral. In starving condition, initially there are 
metabolic and hormonal changes where the body 
shifts its main source of energy from carbohydrate into 
protein and fat, and the basal metabolic rate decreases 
by appro[imately 20-25%.9
In prolonged fasting, the hormonal and metabolic 
changes which happen in the body aim to prevent 
Figure1. Scheme of pathophysiology in refeeding syndrome5
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protein and muscle breakdown. Muscle and other tissue 
organs decrease the use of ketone as main source of 
energy and instead use fatty acid. This can increase 
ketone level in the blood, thus stimulate brain to replace 
glucose with ketone as the main source of energy. 
Liver also decreases the rate of gluconeogenesis; 
thus, muscle protein can be preserved. In long-
term starvation, several minerals which present in 
intracellular compartment will decrease dramatically. 
However, minerals concentration in the blood 
(including phosphate) will remain normal. This is due 
to the homeostasis mechanisms which maintain the 
concentration of those ions in the serum by sacri¿cing 
intracellular storage.1,3 
Nutrition re-administration in malnourished 
patients will cause decreased gluconeogenesis and 
rapid anaerobic metabolism process. This is mediated 
by the rapid increase of insulin during refeeding.10 
Insulin will stimulate potassium, phosphate, and 
magnesium transfer from e[tracellular to intracellular. 
Since the level of these minerals are very low in the 
intracellular compartment, this transfer cause sudden 
decrease of mineral concentration in the e[tracellular 
space.11 Osmotic imbalances which happen suddenly 
due to refeeding is compensated by the body by the 
presence of Àuid and sodium retention to replace 
osmotic balance.1 Reactivation of metabolic pathway 
associated with carbohydrate will increase thiamine 
requirement, a cofactor required for cellular enzymatic 
reaction. This process will lead to the decrease in 
the level of phosphate, potassium, magnesium, and 
thiamine in the serum. The degree of reduction varies 
and may cause different effects in every individual.
CLINICAL MANIFESTATIONS
Clinical manifestations of RS are varied, cannot be 
predicted, appear suddenly, and may also appear later. 
Those clinical manifestations appear as a result of drastic 
changes in serum electrolyte level which inÀuences the 
potential of cell membrane and disturb the function of 
neurons, skeletal muscle cells, and cardiac muscle cells. 
The spectrum of clinical manifestations which appear 
due to RS is very wide, starting from complaints of 
nausea, vomiting, and fatigue until breathing problems, 
heart failure, hypotension, coma, and even death.1,3,5 
Clinical manifestations which are related to electrolyte 
imbalance due to RS is summarized in Table 1.
MANAGEMENT
The management principle of RS is correction of 
biochemical abnormality and Àuid imbalance to reach 
their normal values, if possible. A guideline published 
by National Institute of Health and Clinical ([cellence 
indicated that food administration and biochemical 
abnormality correction which happen in the RS may 
be performed simultaneously without giving bad effect 
to the patient.3,6 However, until now there is still no 
randomized study to support this opinion.
Table 1. Clinical manifestation of refeeding syndrome associated electrolyte imbalance1
Clinical manifestation
Phosphate (PO42-) Hypophosphatemia (normal range 0.8-1.45 mmol/L) presents as 
Cardiovascular: heart failure, arrhythmia, hypotension, cardiomyopathy shock, death
Renal: acute tubular necrosis, metabolic acidosis
Skeleton: rhabdomyolysis, weakness, myalgia, diaphragm weakness
Neurology: delirium, coma, seizures, tetany
Endocrine: hyperglycaemia, insulin resistance, osteomalacia
Haematology: haemolysis, thrombocytopenia, leukocyte dysfunction
Potassium (K+) Hypokalaemia (normal range 3.5-5.1 mmol/L) presents as
Cardiovascular: hypotension, ventricular arrhythmias, cardiac arrest, bradycardia or tachycardia
Respiratory: hypoventilation, respiratory distress, respiratory failure
Skeleton: weakness, fatigue, muscle twitching
Gastrointestinal: diarrhea, nausea, vomiting, anorexia, paralytic ileus, constipation
Metabolic: metabolic alkalosis
Magnesium (Mg2+) Hypomagnesaemia (normal range 0.77-1.33 mmol/L) presents as
Cardiovascular: paroxysmal atrial or ventricular arrhythmias, repolarisation alternans
Respiratory: hypoventilation, respiratory distress, respiratory failure
Neuromuscular: weakness, fatigue, muscle cramps (Trousseau and Chvostek) weakness, ataxia, vertigo, 
paresthesia, hallucinations, depression, convulsions
Gastrointestinal: abdominal pain, diarrhea, vomiting, loss of appetite, and constipation
Other: anaemia, hypocalcemia
NB: many cases of hypomagnesaemia do not manifest clinically till very late
Sodium (Na+) Hyponatremia (normal range 136-145 mmol/L) ensues during RFS due to hyperglycaemia and presents as:
Cardiovascular: heart failure and arrhythmia
Respiratory: respiratory failure, pulmonary oedema
Renal: renal failure
Skeleton: muscle cramps, fatigue, Àuid retention and swelling (oedema)
Vitamins De¿ciency of thiamine (especially in alcoholism) presents as
Neurology: Wernicke-Korsakoff syndrome, Karsakoff’s psychoisis,
Cardiovascular: congestive heart failure and lactic acidosis, beriberi, disease
Skeleton: muscle weakness
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Prevention is the main key in the successful 
management of RS. In this prevention, there are 3 
(three) main basic factors which need to be considered. 
These factors are identi¿cation of individuals at risk 
of RS, monitoring during refeeding, and appropriate 
regiment of diet. Anticipating risk of RS from the 
beginning will prevent the complications. This can 
be performed by detailed history taking accompanied 
with proper physical e[amination and identi¿cation of 
individuals at risk with early involvement of nutritionist 
(dietitian and/or clinical nutrition specialist).1,3-5 
Table 2. High risk individuals for refeeding syndrome1
Anorexia nervosa Chronic alcoholism
Radiation therapy Major stressors without food 
for > 7 days
Oncology patients Postoperative patients
Severe malnutrition (marasmus/
kwashiorkor)
Institutionalized patients
Pathological weight loss Hunger strikes
Stroke (neurological problems) Malabsorption diseases
InÀammatory bowel disease Post bariatric surgery
Chronic pancreatitis Elderly, poor social 
circumstance
$cTuired Immunode¿ciency 
Syndrome
Diabetes Mellitus
Table 3. Monitoring in patients with risk of refeeding syndrome1
Clinical monitoring Biochemical monitoring
Early identi¿cation of high risk 
patients
Monitor biochemistry and 
electrolyte levels
Monitor blood pressure and pulse 
rate
Monitor blood glucose levels
Monitor feeding rate ECG monitoring in severe 
case
Meticulously document Àuid intake 
and output
Account other sources of 
energy
Monitor change in body weight (dextrose, propofol, 
medications)
Monitor for neurologic signs and 
symptoms
Patient education
CONCLUSION
All clinicians who treat patients at risk and require 
nutrition administration need to identify the risk of 
RS. The lack of randomized controlled trial study 
in this treatment means that the management of RS 
is still based on non-evidence based, anecdotal data. 
This highlights the importance of minimizing the risk 
of RS by carefully reintroducing food. RS is also a 
spectrum of disease happening in particular condition 
in high risk population.
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Table 4. Recommendation of food administration for individuals with risk of refeeding syndrome1,6
Day Calorie intake (all feeding routes) Supplements
Day 1 10 kcal/kg/day
For extreme cases
(BMI < 14 kg/m2 or no food > 15 days)
5 kcal/kg/day
Carbohydrate: 50-60%
Fat: 30-40%
Protein: 15-20%
Prophylactic supplement
PO42-: 0.5-0.8 mmol/kg/day
K+: 1-3 mmol/kg/day
Mg2+: 0.3-0.4 mmmol/kg/day
Na+: < 1 mmol/kg/day (restricted)
IV Àuids-restricted, maintain ³zero´ balance
IV Thiamine + vitamin B complex 30 minutes prior to feeding
Day 2-4 Increase by 5 kcal/kg/day
If low or no tolerance stop or keep
minimal feeding regime
Check all biochemistry and correct any abnormality
Thiamine + vitamin B complex orally or IV till day 3
Monitoring as required (Table 3)
Day 5-7 20-30 kcal/kg/day Check electrolytes, renal and liver functions and minerals
Fluid: maintain zero balance
Consider iron supplement from day 7
Day 8-10 30 kcal/kg/day or increase to full requirement Monitor as required (Table 3)
Currently, there are many publications regarding 
regiment for food administration in individuals at 
risk of RS. All of them are not evidence-based. In 
food administration of these at risk individuals, the 
main principle needs to be followed is underfeeding 
permissive principle.1 Below is the recommendation of 
food administration based on guidelines, publication, 
and e[perts¶ opinions (Table 4).
